<PAGE>
PROSPECTUS Rule 424(b)(3)
Registration No. 33-99282
COMPUSA INC.
6,394,368 SHARES
OF
COMMON STOCK*
This Prospectus has been prepared by CompUSA Inc., a Delaware corporation
(the "Company"), for use upon resale by certain directors, officers and
employees of the Company (the "Selling Stockholders") of up to 6,394,368 shares
of the Company's common stock, par value $.01 per share ("Common Stock"). The
Selling Stockholders have acquired and/or may in the future acquire shares of
Common Stock from the Company pursuant to awards granted from time to time to
the Selling Stockholders under the Company's Long-Term Incentive Plan (the
"Plan").
The Common Stock may be sold from time to time by the Selling Stockholders
or permitted transferees. Such sales may be sold on one or more exchanges,
including the New York Stock Exchange ("NYSE"), in the over-the-counter market
or in negotiated transactions, in each case at prices and at terms then
prevailing or at prices related to the then current market price or at
negotiated prices and terms. See "Plan of Distribution." Upon any sale of the
Common Stock offered hereby, the Selling Stockholders or permitted transferees
and participating agents, brokers, dealers and marketmakers may be deemed to be
underwriters as that term is defined in the Securities Act of 1933, as amended
(the "Securities Act"), and commissions or discounts or any profit realized on
the resale of such securities purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act.
The Common Stock is listed for trading on the NYSE under the symbol "CPU."
On July 5, 1996, the last reported sale price of the Common Stock, as reported
on the NYSE Composite Transactions Tape, was $36.375. The Company will pay all
expenses in connection with this offering, which are estimated to be
approximately $22,000.
* This figure is an estimate. The Company has filed Registration Statements on
Form S-8, Registration Numbers 33-72718, 33-45339 and 33-99282 (of which this
Prospectus is a part), which Registration Statements cover the sale by the
Company of Common Stock issuable pursuant to awards granted or to be granted
under the Plan. This Prospectus covers the resale by the Selling Stockholders
of an indeterminate number of shares of Common Stock acquired or that may be
acquired by the Selling Stockholders pursuant to awards granted or to be
granted to the Selling Stockholders under the Plan.
_________________
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED
UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.
The date of this Prospectus is July 8, 1996.
<PAGE>
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith, files reports, proxy statements and other information with the
Securities and Exchange Commission (the "Commission"). Such reports, proxy
statements and other information can be inspected and copied at the public
reference facilities maintained by the Commission at Judiciary Plaza, Room 1024,
450 Fifth Street, N.W., Washington, D.C. 20549, and at the Commission's regional
offices at 500 West Madison Street, Suite 1400, Chicago, Illinois 60661-2511 and
at Seven World Trade Center, Suite 1300, New York, New York 10048. Copies of
such materials can also be obtained from the Public Reference Section of the
Commission at 450 Fifth Street, N.W., Washington, D.C. 20549, at prescribed
rates. The Common Stock is listed on the NYSE. Reports, proxy statements and
other information concerning the Company can also be inspected and copied at the
offices of the NYSE at 20 Broad Street, New York, New York 10005.
This Prospectus constitutes part of a Registration Statement on Form S-8
(the "Registration Statement") filed by the Company with the Commission under
the Securities Act. This Prospectus omits certain of the information contained
in the Registration Statement and the exhibits thereto, in accordance with the
rules and regulations of the Commission. For further information concerning the
Company and the Common Stock, reference is made to the Registration Statement
and the exhibits filed therewith, which may be inspected without charge at the
office of the Commission at 450 Fifth Street, N.W., Washington, D.C. 20549 and
copies of which may be obtained from the Commission at prescribed rates. Any
statements contained herein concerning the provisions of any documents are not
necessarily complete, and, in each instance, reference is made to the copy of
such document filed as an exhibit to the Registration Statement or otherwise
filed with the Commission. Each such statement is qualified in its entirety by
such reference.
The Company's principal executive offices are located at 14951 North Dallas
Parkway, Dallas, Texas 75240, and the Company's telephone number is (214) 982-
4000.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents filed by the Company by the Company with the
Commission pursuant to the Exchange Act are incorporated by reference in this
Prospectus:
(i) Annual Report on Form 10-K for the year ended June 24, 1995;
(ii) Quarterly Report on Form 10-Q for the quarter ended September 23,
1995;
(iii) Quarterly Report on Form 10-Q for the quarter ended December 23,
1995;
(iv) Quarterly Report on Form 10-Q for the quarter ended March 23, 1996;
-2-
<PAGE>
(v) Current Report on Form 8-K, filed with the Commission on May 20,
1996;
(vi) Current Report on Form 8-K, filed with the Commission on June 14,
1996; and
(vii) The description of the Company's Common Stock contained in the
Company's Registration Statement on Form 8-A/A (No. 1-11566) filed
November 14, 1995, as amended.
All reports and other documents subsequently filed by the Company pursuant
to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after the date
of this Prospectus and prior to the termination of this offering (the
"Offering") shall be deemed to be incorporated by reference in this Prospectus
and to be a part hereof from the date of the filing of such documents. Any
statement contained in a document incorporated by reference shall be deemed to
be modified or superseded for purposes of this Prospectus to the extent that a
statement contained herein or in any other subsequently filed document which
also is or is deemed to be incorporated by reference herein or in any
accompanying prospectus supplement modifies or supersedes such statement. Any
such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Prospectus.
The Company will provide without charge to each person to whom a copy of
this Prospectus is delivered, upon written or oral request, a copy of any or all
of the documents incorporated herein by reference (without exhibits to such
documents, unless such exhibits are specifically incorporated by reference into
such documents). Requests should be directed in writing to CompUSA Inc., 14951
North Dallas Parkway, Dallas, Texas 75240, Attention: Assistant Secretary, or by
telephone at (214) 982-4000.
USE OF PROCEEDS
The Company will not receive any proceeds from the sale of the Common Stock
offered hereby.
SELLING STOCKHOLDERS
Information relating to the Selling Stockholders will be provided by
Prospectus Supplement.
-3-
<PAGE>
PLAN OF DISTRIBUTION
The Common Stock offered hereby may be sold from time to time by the
Selling Stockholders or permitted transferees. The Common Stock may be disposed
of from time to time in one or more transactions through any one or more of the
following: (i) to purchasers directly, (ii) in ordinary brokerage transactions
and transactions in which the broker solicits purchasers, (iii) through
underwriters or dealers who may receive compensation in the form of underwriting
discounts, concessions or commissions from the Selling Stockholders or permitted
transferees and/or from the purchasers of the Common Stock for whom they may
act, (iv) the writing of options on the Common Stock, (v) the pledge of the
Common Stock as security for any loan or obligation, including pledges to
brokers or dealers who may, from time to time, themselves effect distributions
of the Common Stock or interests therein, (vi) purchases by a broker or dealer
as principal and resale by such broker or dealer for its own account pursuant to
this Prospectus, (vii) a block trade in which the broker or dealer engaged in
such block trade will attempt to sell the Common Stock as agent but may position
and resell a portion of the block as principal to facilitate the transaction and
(viii) an exchange distribution in accordance with the rules of the applicable
exchange, or in transactions in the over the counter market. Such sales may be
made at prices and at terms then prevailing or at prices related to the then
current market price or at negotiated prices and terms. In effecting sales,
brokers or dealers may arrange for other brokers or dealers to participate. The
Selling Stockholders or permitted transferees and any underwriters, brokers,
dealers or agents that participate in the distribution of the Common Stock may
be deemed to be "underwriters" within the meaning of the Securities Act and any
profit on the sale of the Common Stock by them and any discounts, commissions or
concessions received by any such underwriters, brokers, dealers or agents may be
deemed to be underwriting commissions or discounts under the Securities Act. In
addition, while this Prospectus covers the offering and sale of the securities
noted above, such securities may also qualify for sale pursuant to Rule 144
promulgated under the Securities Act ("Rule 144"), and accordingly such
securities may be sold under Rule 144 rather than pursuant to this Prospectus.
The Company will pay all of the expenses incident to the offering and sale
of the Common Stock to the public other than underwriting discounts or
commissions, brokers' fees and the fees and expenses of any counsel to the
Selling Stockholders related thereto.
LEGAL MATTERS
Certain legal matters in connection with the validity of the Common Stock
offered hereby have been passed upon by Jackson & Walker, L.L.P., Dallas, Texas.
EXPERTS
The consolidated financial statements of the Company appearing in the
Company's Annual Report on Form 10-K for the year ended June 24, 1995, have been
audited by Ernst & Young LLP,
-4-
<PAGE>
independent auditors, as set forth in their report thereon included therein and
incorporated herein by reference. Such consolidated financial statements are,
and audited financial statements to be included in subsequently filed documents
will be, incorporated herein in reliance upon the reports of Ernst & Young LLP
pertaining to such financial statements (to the extent covered by consents filed
with the Commission) given upon the authority of such firm as experts in
accounting and auditing.
INDEMNIFICATION
The Company is a Delaware corporation and the Delaware General Corporation
Law (the "Delaware Law") empowers a corporation organized thereunder to
indemnify its directors and officers or former directors and officers and to
purchase insurance with respect to liability arising out of their capacity or
status as directors and officers.
Reference is made to Article VII of the Company's Restated and Amended
Bylaws, which provides for indemnification of directors and officers except as
to certain circumstances and except as provided by applicable law.
Additionally, Article VI ("Article VI") of the Company's Restated and
Amended Certificate of Incorporation limits the personal liability of directors
of the Company to the Company or its stockholders for monetary damages for
breach of fiduciary duty as a director, notwithstanding any provision of law
imposing such liability; provided that to the extent required from time to time
by applicable law, Article VI shall not eliminate or limit the liability of a
director, to the extent such liability is provided by applicable law, (i) for
any breach of the director's duty of loyalty to the Company or its stockholders,
(ii) for acts or omissions not in good faith or which involve intentional
misconduct or a knowing violation of law, (iii) under Section 174 of Title 8 of
the Delaware Law, or (iv) for any transaction from which the director derived an
improper personal benefit.
Insofar as indemnification for liabilities arising under the Securities Act
of 1933, as amended (the "Securities Act"), may be permitted to directors,
officers or persons controlling the Company pursuant to the foregoing
provisions, the Company has been informed that in the opinion of the Commission,
such indemnification is against public policy as expressed in the Securities Act
and is therefore unenforceable.
-5-
<PAGE>
No dealer, salesperson or other person has
been authorized to give any information or to
make any representation not contained in this
Prospectus in connection with the offering
made hereby and, if given or made, such
information or representation must not be
relied upon as having been authorized by the
Company. This Prospectus does not
constitute an offer to sell or a solicitation of COMPUSA INC.
an offer to buy any securities in any
jurisdiction to any person to whom it would
be unlawful to make such an offer or
solicitation in such jurisdiction. Neither the
delivery of this Prospectus nor any sale made 6,394,368 SHARES
under any circumstances, create any COMMON STOCK
implication that the information contained
herein is correct as of any time subsequent
to the date hereof or that there has been
no change in the affairs of the Company
since such date.
______________________
TABLE OF CONTENTS PROSPECTUS
Page
Incorporation of Certain Documents
by Reference........................... 2
Use of Proceeds......................... 3
Selling Stockholders.................... 3
Plan of Distribution.................... 4
Legal Matters........................... 4
Experts................................. 4
Indemnification......................... 5
